|
VAERS ID: |
1133722 (history) |
Form: |
Version 2.0 |
Age: |
56.0 |
Sex: |
Male |
Location: |
Maryland |
Vaccinated: |
2021-03-13 |
Onset: |
2021-03-19 |
Days after vaccination: |
6 |
Submitted: |
0000-00-00 |
Entered: |
2021-03-25 |
Vaccination / Manufacturer |
Lot / Dose |
Site / Route |
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN |
- / UNK |
- / - |
Administered by: Private Purchased by: ? Symptoms: Areflexia, CSF glucose normal, CSF protein increased, CSF red blood cell count, CSF white blood cell count increased, Guillain-Barre syndrome, Hypoaesthesia, Muscular weakness SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad) Life Threatening? No Birth Defect? No Died? No Permanent Disability? No Recovered? No Office Visit? No ER Visit? No ER or Doctor Visit? No Hospitalized? Yes, 2 days Extended hospital stay? No Previous Vaccinations: Other Medications: NAC, Rehmannia 6 supplements and Maca root supplements. Current Illness: none known Preexisting Conditions: none known Allergies: none known Diagnostic Lab Data: Lumbar puncture (3/23): CSF labs: 3/23/2021: Glucose, CSF 60 mg/dL; Protein,Total, CSF 74.0 mg/dL; Red Blood Count, CSF 21,000 /cu mm; Red Blood Count, CSF 1,000 /cu mm; White Blood Count, CSF 39 /cu mm; White Blood Count, CSF 6 /cu mm CDC Split Type: Write-up: Beginning on 3/19 he developed a progressive ascending numbness first in his toes, then progressing to include bilateral legs up to knees and bilateral arms up to mid forearm. He also had mild leg weakness bilaterally. He has absent reflexes. His lumbar puncture showed albuminocytologic dissociation. He was diagnosed with Guillan-Barre syndrome and is being treated with IVIG. |
|
VAERS ID: |
1134203 (history) |
Form: |
Version 2.0 |
Age: |
55.0 |
Sex: |
Male |
Location: |
Florida |
Vaccinated: |
2021-03-06 |
Onset: |
2021-03-17 |
Days after vaccination: |
11 |
Submitted: |
0000-00-00 |
Entered: |
2021-03-25 |
Vaccination / Manufacturer |
Lot / Dose |
Site / Route |
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN |
- / UNK |
LA / IM |
Administered by: Unknown Purchased by: ? Symptoms: CSF glucose normal, CSF lymphocyte count normal, CSF neutrophil count increased, CSF protein increased, CSF white blood cell count, Computerised tomogram head normal, Computerised tomogram spine, Guillain-Barre syndrome, Lumbar puncture SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow) Life Threatening? No Birth Defect? No Died? No Permanent Disability? No Recovered? No Office Visit? No ER Visit? No ER or Doctor Visit? No Hospitalized? Yes, ? days Extended hospital stay? No Previous Vaccinations: Other Medications: None Current Illness: none Preexisting Conditions: Prostate cancer Esophageal reflux disease Hypercholesterolemia Allergies: None Diagnostic Lab Data: Normal Brain Ct scan Normal Spine Ct scan Lumbar puncture: 4wbc, 12 % neutrophile, 76 % lymphocytes; Protein: 162; Glucose: 61 CDC Split Type: Write-up: Guillan-Barre syndrome |
|
VAERS ID: |
1144847 (history) |
Form: |
Version 2.0 |
Age: |
72.0 |
Sex: |
Female |
Location: |
Virginia |
Vaccinated: |
2021-03-08 |
Onset: |
2021-03-15 |
Days after vaccination: |
7 |
Submitted: |
0000-00-00 |
Entered: |
2021-03-29 |
Vaccination / Manufacturer |
Lot / Dose |
Site / Route |
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN |
- / 1 |
- / IM |
Administered by: Unknown Purchased by: ? Symptoms: Guillain-Barre syndrome SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow) Life Threatening? Yes Birth Defect? No Died? No Permanent Disability? Yes Recovered? No Office Visit? No ER Visit? No ER or Doctor Visit? Yes Hospitalized? Yes, ? days Extended hospital stay? No Previous Vaccinations: Other Medications: Current Illness: Preexisting Conditions: -Cognitive impairment -Hypercholesterolemia Allergies: Penicillins Diagnostic Lab Data: CDC Split Type: Write-up: Guillain Barre syndrome |
|
VAERS ID: |
1146222 (history) |
Form: |
Version 2.0 |
Age: |
61.0 |
Sex: |
Male |
Location: |
Texas |
Vaccinated: |
2021-03-08 |
Onset: |
2021-03-23 |
Days after vaccination: |
15 |
Submitted: |
0000-00-00 |
Entered: |
2021-03-30 |
Vaccination / Manufacturer |
Lot / Dose |
Site / Route |
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN |
1805018 / N/A |
LA / IM |
Administered by: Other Purchased by: ? Symptoms: Asthenia, Dysarthria, Facial paralysis, Fall, Gait inability, Guillain-Barre syndrome, Hypoaesthesia, Hypoaesthesia oral, Intensive care, Muscular weakness, Paralysis SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Anticholinergic syndrome (broad), Dystonia (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Accidents and injuries (narrow), Demyelination (narrow), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Hearing impairment (broad), Hypoglycaemia (broad), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad) Life Threatening? No Birth Defect? No Died? No Permanent Disability? No Recovered? No Office Visit? No ER Visit? No ER or Doctor Visit? Yes Hospitalized? Yes, 5 days Extended hospital stay? No Previous Vaccinations: Other Medications: Atorvastin Lisinopril Carvedilol Current Illness: none Preexisting Conditions: CHF Allergies: NONE none Diagnostic Lab Data: unit being monitored--- has been diagnosed with Guillian Barre syndrome awaiting test results and is to receive immunoglobulin intravenously. Possible unable to swallow without aspirating. CDC Split Type: Write-up: started getting numbness in hands-fingers and lips and then numbness to feet and fell to ground with inability to walk - no strength in legs knees or arms. left facial drooping and slurring of speech and severe weakness -paralyzed |
|
VAERS ID: |
1163209 (history) |
Form: |
Version 2.0 |
Age: |
57.0 |
Sex: |
Male |
Location: |
Connecticut |
Vaccinated: |
2021-03-05 |
Onset: |
2021-03-17 |
Days after vaccination: |
12 |
Submitted: |
0000-00-00 |
Entered: |
2021-04-03 |
Vaccination / Manufacturer |
Lot / Dose |
Site / Route |
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN |
- / UNK |
LA / IM |
Administered by: Private Purchased by: ? Symptoms: Guillain-Barre syndrome, Hypoaesthesia, Paralysis, Pneumonia, Vaccination complication SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Demyelination (narrow), Eosinophilic pneumonia (broad), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (narrow), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad) Life Threatening? Yes Birth Defect? No Died? No Permanent Disability? Yes Recovered? No Office Visit? No ER Visit? No ER or Doctor Visit? Yes Hospitalized? Yes, 10 days Extended hospital stay? No Previous Vaccinations: Other Medications: None Current Illness: None Preexisting Conditions: None Allergies: None Diagnostic Lab Data: CDC Split Type: Write-up: Numbness in extremities, paralysis full body. Pneumonia left lung. Now diagnosed with Guillain-Barre syndrome, due to reaction to covid-19 vaccine |
|
VAERS ID: |
1166746 (history) |
Form: |
Version 2.0 |
Age: |
39.0 |
Sex: |
Female |
Location: |
Washington |
Vaccinated: |
2021-03-14 |
Onset: |
2021-03-26 |
Days after vaccination: |
12 |
Submitted: |
0000-00-00 |
Entered: |
2021-04-04 |
Vaccination / Manufacturer |
Lot / Dose |
Site / Route |
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN |
1805029 / 1 |
LA / IM |
Administered by: Private Purchased by: ? Symptoms: Asthenia, Guillain-Barre syndrome, Hypoaesthesia, Immunoglobulin therapy, Muscular weakness SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad) Life Threatening? No Birth Defect? No Died? No Permanent Disability? Yes Recovered? No Office Visit? No ER Visit? No ER or Doctor Visit? No Hospitalized? Yes, ? days Extended hospital stay? No Previous Vaccinations: Other Medications: vitamin D, vitamin B-12 Current Illness: Preexisting Conditions: depression, vitamin D deficiency Allergies: no known allergies Diagnostic Lab Data: CDC Split Type: Write-up: Symptoms started as numbness and weakness in her feet which progressed to her hands, and eventually whole body. Diagnosis is Guillain-Barre syndrome. Remains hospitalized and receiving IVIG. |
|
VAERS ID: |
1172339 (history) |
Form: |
Version 2.0 |
Age: |
59.0 |
Sex: |
Male |
Location: |
Virginia |
Vaccinated: |
2021-03-11 |
Onset: |
2021-03-18 |
Days after vaccination: |
7 |
Submitted: |
0000-00-00 |
Entered: |
2021-04-06 |
Vaccination / Manufacturer |
Lot / Dose |
Site / Route |
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN |
1802072 / 1 |
UN / IM |
Administered by: Private Purchased by: ? Symptoms: Guillain-Barre syndrome, Hypoaesthesia, Lumbar puncture, Muscular weakness SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad) Life Threatening? No Birth Defect? No Died? No Permanent Disability? No Recovered? No Office Visit? No ER Visit? No ER or Doctor Visit? No Hospitalized? Yes, ? days Extended hospital stay? No Previous Vaccinations: Other Medications: amLODIPine aspirin 81 mg Tablet, diazePAM gabapentin hydroCHLOROthiazide losartan nitroglycerin omeprazole oxyCODONE-acetaminophen potassium chloride SA (K-DUR) tiZANidine Current Illness: Preexisting Conditions: Type 2 DM, GERD, Chronic low back pain Allergies: NKA Diagnostic Lab Data: Lumbar puncture on 04/03/21 CDC Split Type: Write-up: A week after the patient had the vaccine he developed weakness with numbness in the lower extremities. Patient continued to get worse and was admitted on 04/03 with concerns for Guillain-Barr? syndrome ( GBS). Patient is currently getting treatment for GBS. |
|
VAERS ID: |
1172503 (history) |
Form: |
Version 2.0 |
Age: |
69.0 |
Sex: |
Male |
Location: |
New York |
Vaccinated: |
2021-03-11 |
Onset: |
2021-03-25 |
Days after vaccination: |
14 |
Submitted: |
0000-00-00 |
Entered: |
2021-04-06 |
Vaccination / Manufacturer |
Lot / Dose |
Site / Route |
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN |
1802072 / 1 |
RA / - |
Administered by: Pharmacy Purchased by: ? Symptoms: Asthenia, CSF protein increased, Guillain-Barre syndrome, Lumbar puncture abnormal, White blood cell count decreased SMQs:, Haematopoietic leukopenia (narrow), Peripheral neuropathy (narrow), Systemic lupus erythematosus (broad), Guillain-Barre syndrome (narrow), Demyelination (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (narrow) Life Threatening? No Birth Defect? No Died? No Permanent Disability? No Recovered? No Office Visit? No ER Visit? No ER or Doctor Visit? No Hospitalized? Yes, 5 days Extended hospital stay? No Previous Vaccinations: Other Medications: Valsartan-HCTZ, rosuvastain, ASA Current Illness: None Preexisting Conditions: HTN, HLD Allergies: No known allergies Diagnostic Lab Data: Lumbar puncture with CSF protein 219, WBC 3 CDC Split Type: Write-up: Patient with progressive ascending weakness over 2 weeks. Diagnosed with Guillain-Barre Syndrome. |
|
VAERS ID: |
1181925 (history) |
Form: |
Version 2.0 |
Age: |
57.0 |
Sex: |
Male |
Location: |
Delaware |
Vaccinated: |
2021-03-15 |
Onset: |
2021-03-20 |
Days after vaccination: |
5 |
Submitted: |
0000-00-00 |
Entered: |
2021-04-08 |
Vaccination / Manufacturer |
Lot / Dose |
Site / Route |
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN |
1805018 / N/A |
LA / UN |
Administered by: Pharmacy Purchased by: ? Symptoms: Back pain, CSF protein, Computerised tomogram, Condition aggravated, Death, Gait disturbance, Guillain-Barre syndrome, Immunoglobulin therapy, Magnetic resonance imaging, Mechanical ventilation, Muscular weakness, Pain, Paraesthesia, X-ray SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Anticholinergic syndrome (broad), Retroperitoneal fibrosis (broad), Parkinson-like events (broad), Acute central respiratory depression (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow), Respiratory failure (broad), Hypoglycaemia (broad), Immune-mediated/autoimmune disorders (narrow) Life Threatening? Yes Birth Defect? No Died? Yes
Date died: 2021-04-06
Days after onset: 17 Permanent Disability? No Recovered? No Office Visit? No ER Visit? No ER or Doctor Visit? Yes Hospitalized? Yes, 10 days Extended hospital stay? No Previous Vaccinations: Other Medications: See additional space, Long list. Current Illness: Car accident on 2/26, so neck and Lumbar pain. Preexisting Conditions: Heart Failure ~ 2017, Stroke ~ 2019, Hypertension, Diabetes. Allergies: N/A Diagnostic Lab Data: I know they did an MRI and a CAT scan, an X-Ray, and they did a protein test on his spinal fluid. He also completed a course of Immunoglobulin therapy for GBS. CDC Split Type: Write-up: Patient started complaining of extreme back pain and trouble walking within days after receiving the vaccine. His pain got increasingly worse. On the 23rd he had to be taken into the hospital in an ambulance. He said he felt as if his lower body was separated from his torso, and visible was having trouble walking. They prescribed him Valium, preformed an x-ray, and sent him home. On the 27th he was taken back to the hospital due to leg weakness, tingling in his hands and feet, and extreme pain. He was diagnosed with Guillain-Barre Syndrome. He passed away April 6, 2021 after spending 11 days in the hospital, and 6 days on a ventilator. |
|
VAERS ID: |
1182108 (history) |
Form: |
Version 2.0 |
Age: |
66.0 |
Sex: |
Female |
Location: |
Oregon |
Vaccinated: |
2021-03-09 |
Onset: |
2021-04-03 |
Days after vaccination: |
25 |
Submitted: |
0000-00-00 |
Entered: |
2021-04-08 |
Vaccination / Manufacturer |
Lot / Dose |
Site / Route |
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN |
- / 1 |
AR / IM |
Administered by: Unknown Purchased by: ? Symptoms: Areflexia, Facial paralysis, Facial paresis, Guillain-Barre syndrome, Immunoglobulin therapy, Magnetic resonance imaging head abnormal SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious meningitis (broad), Demyelination (narrow), Hearing impairment (broad), Immune-mediated/autoimmune disorders (narrow) Life Threatening? No Birth Defect? No Died? No Permanent Disability? Yes Recovered? No Office Visit? No ER Visit? No ER or Doctor Visit? Yes Hospitalized? Yes, 5 days Extended hospital stay? No Previous Vaccinations: Other Medications: lorazepam prn Current Illness: Preexisting Conditions: Anxiety Allergies: None Diagnostic Lab Data: MRI brain WWO 4/8/2021: "The subtle enhancement of the 7th and 8th nerve complex is unusual in that it is bilateral. It does, however, correlate with the reported consultation note of Dr. in the electronic medical record. An inflammatory process is favored." CDC Split Type: Write-up: Patient developed bilateral facial weakness starting on 4/3/2021, progressed over the course of five days until she presented to the emergency department on 4/8/2021. Exam with bilateral CN VII palsy and lower extremity areflexia. MRI brain shows enhancement of bilateral CN VII and VIII. Suspect GBS, treating with IVIG. |
|